{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:13:00Z","timestamp":1790064780290,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejim.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:11:46Z","timestamp":1568160706000},"page":"6-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["The pituitary in nuclear medicine imaging"],"prefix":"10.1016","volume":"68","author":[{"given":"Pedro","family":"Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2019.08.008_bb0005","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1148\/rg.2018180072","article-title":"Mechanisms of uptake of common radiopharmaceuticals RadioGraphics fundamentals | online presentation","volume":"38","author":"Lim","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.ejim.2019.08.008_bb0010","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00259-010-1571-5","article-title":"Incidental pituitary uptake on whole-body 18F-FDG PET\/CT: a multicentre study","volume":"37","author":"Jeong","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejim.2019.08.008_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.110.083733","article-title":"Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria","volume":"52","author":"Hyun","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0020","doi-asserted-by":"crossref","first-page":"55544","DOI":"10.18632\/oncotarget.15417","article-title":"Evaluation of pituitary uptake incidentally identified on (18)F-FDG PET\/CT scan","volume":"8","author":"Ju","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejim.2019.08.008_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11102-008-0162-y","article-title":"Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma","volume":"14","author":"Fusco","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ejim.2019.08.008_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-017-1486-z","article-title":"Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma","volume":"60","author":"Del Gatto","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ejim.2019.08.008_bb0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1148\/radiology.189.3.8234714","article-title":"Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction","volume":"189","author":"Zasadny","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.ejim.2019.08.008_bb0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.RLU.0000057554.55930.05","article-title":"Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma","volume":"28","author":"Campeau","year":"2003","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0045","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/RLU.0b013e3182639765","article-title":"Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab","volume":"38","author":"van der Hiel","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.177.1.2399336","article-title":"Pituitary microadenomas: a PET study","volume":"177","author":"De Souza","year":"1990","journal-title":"Radiology"},{"issue":"826\u2013833","key":"10.1016\/j.ejim.2019.08.008_bb0055","article-title":"Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies","volume":"28","author":"Francavilla","year":"1991","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejim.2019.08.008_bb0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","author":"Seok","year":"2013","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MNM.0000000000000940","article-title":"Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET\/CT","volume":"40","author":"Ding","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejim.2019.08.008_bb0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","article-title":"Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination","volume":"104","author":"Arita","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejim.2019.08.008_bb0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11102-015-0652-7","article-title":"Pituitary incidentalomas: analysis of a neuroradiological cohort","volume":"18","author":"Esteves","year":"2015","journal-title":"Pituitary."},{"issue":"81\u2013117","key":"10.1016\/j.ejim.2019.08.008_bb0080","first-page":"vi","article-title":"Differential diagnosis of sellar masses","volume":"28","author":"Freda","year":"1999","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.ejim.2019.08.008_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.acra.2016.08.005","article-title":"Immune-mediated disease in ipilimumab immunotherapy of melanoma with FDG PET-CT","volume":"24","author":"Wachsmann","year":"2017","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejim.2017.08.019","article-title":"Cancer immunotherapy-induced endocrinopathies: clinical behavior and therapeutic approach","volume":"47","author":"Iglesias","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/RLU.0000000000001981","article-title":"Superior pituitary border analysis in immunotherapy-induced hypophysitis","volume":"43","author":"Pucar","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2018.03.006","article-title":"Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1","volume":"96","author":"Mekki","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejim.2019.08.008_bb0105","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/RLU.0000000000000793","article-title":"Pituitary 18F-FDG uptake correlates with serum TSH levels in subjects with diffuse thyroid 18F-FDG uptake","volume":"40","author":"Jeong","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2967\/jnumed.117.191916","article-title":"PET\/MRI in the diagnosis of hormone-producing pituitary microadenoma: a prospective pilot study","volume":"59","author":"Wang","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mce.2017.10.003","article-title":"Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1","volume":"470","author":"Lu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease","volume":"65","author":"Boyle","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ejim.2019.08.008_bb0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3171\/2014.12.JNS14870","article-title":"Pituitary metastases: current practice in Japan","volume":"123","author":"Habu","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejim.2019.08.008_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/RLU.0000000000002037","article-title":"Metastasis to the Sellar\/Suprasellar region in a patient with endometrial carcinoma detected by 18F-FDG PET\/CT","volume":"43","author":"Salvatore","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11102-018-0899-x","article-title":"Twelve cases of pituitary metastasis: a case series and review of the literature","volume":"21","author":"Castle-Kirszbaum","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ejim.2019.08.008_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/sni.sni_229_18","article-title":"Enlargement of Langerhans cell histiocytosis of the hypothalamus with progression into the basal ganglia and white matter","volume":"9","author":"Tamai","year":"2018","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.ejim.2019.08.008_bb0145","first-page":"90","article-title":"111In-[DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas","volume":"39","author":"Boni","year":"1995","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0150","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF03343538","article-title":"The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas","volume":"22","author":"Colao","year":"1999","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.ejim.2019.08.008_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MNM.0000000000000931","article-title":"Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas","volume":"40","author":"Vukomanovic","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"589\u2013598","key":"10.1016\/j.ejim.2019.08.008_bb0160","article-title":"Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide","volume":"47","author":"Broson-Chazot","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/eje.0.1360369","article-title":"Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology","volume":"136","author":"Plockinger","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11102-011-0370-8","article-title":"Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study","volume":"15","author":"Fusco","year":"2012","journal-title":"Pituitary."},{"key":"10.1016\/j.ejim.2019.08.008_bb0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0180","first-page":"16","article-title":"Physiological distribution of 68Ga-DOTA-TATE: an atlas of standardized uptake values","volume":"56","author":"Moradi","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/RLU.0b013e3182a77b78","article-title":"68Ga DOTATATE PET\/CT in a rare coexistence of pituitary macroadenoma and multiple paragangliomas","volume":"39","author":"Parghane","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0190","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/RLU.0000000000000535","article-title":"CyberKnife radiosurgery planning of a secreting pituitary adenoma performed with (6)(8)Ga DOTATATE PET and MRI","volume":"39","author":"d'Amico","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/RLU.0000000000001021","article-title":"68Ga DOTATATE PET\/CT of synchronous meningioma and prolactinoma","volume":"41","author":"Basu","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidaladenomectomy","volume":"39","author":"Zhao","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0205","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/RLU.0000000000001628","article-title":"Pituitary adenoma recurrence suspected on central hyperthyroidism despite empty sella and confirmed by 68Ga-DOTA-TOC PET\/CT","volume":"42","author":"Gauthe","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0210","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/RLU.0000000000000462","article-title":"Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET\/CT","volume":"40","author":"Xiao","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/RLU.0000000000000589","article-title":"The use of (68)Ga DOTATATE PET\/CT for diagnostic assessment and monitoring of (177)Lu DOTATATE therapy in pituitary carcinoma","volume":"40","author":"Novruzov","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02988238","article-title":"Is technetium-99m-MIBI taken up by the normal pituitary gland? A comparison of normal pituitary glands and pituitary adenomas","volume":"15","author":"Kojima","year":"2001","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1450-1147.98721","article-title":"Pituitary incidentalomas detected with technetium-99m MIBI in patients with suspected parathyroid adenoma: preliminary results","volume":"11","author":"Tiktinsky","year":"2012","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0230","first-page":"295","article-title":"Clinical significance of incidental pituitary TC-99m MIBI uptake on parathyroid spect and factors affecting uptake intensity","volume":"33","author":"Araz","year":"2018","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ejim.2019.08.008_bb0235","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/RLU.0000000000001318","article-title":"18F-DOPA PET\/CT physiological distribution and pitfalls: experience in 215 patients","volume":"41","author":"Calabria","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0240","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1097\/RLU.0000000000002202","article-title":"18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma","volume":"43","author":"Heimburger","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0245","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2019.08.008_bb0250","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1097\/RLU.0b013e31824c5dd0","article-title":"Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET\/MRI evaluation","volume":"37","author":"Mertens","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0255","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1097\/RLU.0000000000001328","article-title":"Pituitary non-functioning adenoma disclosed at 18F-choline PET\/CT to investigate a prostate cancer relapse","volume":"41","author":"Maffione","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0260","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/RLU.0000000000001889","article-title":"Ectopic adrenocorticotropic hormone-secreting pituitary adenoma localized by 18F-choline PET\/CT","volume":"43","author":"Sindoni","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00004728-198705000-00003","article-title":"Amino acid distribution and metabolism in pituitary adenomas using positron emission tomography with D-[11C]methionine and L-[11C]methionine","volume":"11","author":"Bergstrom","year":"1987","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.ejim.2019.08.008_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00259-005-1882-0","article-title":"11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas","volume":"33","author":"Tang","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejim.2019.08.008_bb0275","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.wneu.2013.11.011","article-title":"Clinical usefulness of coregistered 11C-methionine positron emission tomography\/3-T magnetic resonance imaging at the follow-up of acromegaly","volume":"82","author":"Rodriguez-Barcelo","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ejim.2019.08.008_bb0280","doi-asserted-by":"crossref","first-page":"M107","DOI":"10.1530\/EJE-15-0616","article-title":"A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome","volume":"173","author":"Koulouri","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0285","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-16-0639","article-title":"Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI","volume":"175","author":"Koulouri","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0290","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/RLU.0000000000001085","article-title":"Utility of 11C-methionine and 18F-FDG PET\/CT in patients with functioning pituitary adenomas","volume":"41","author":"Feng","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0295","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-8587(16)30311-4","article-title":"Localisation of an occult thyrotropinoma with (11)C-methionine PET-CT before and after somatostatin analogue therapy","volume":"4","author":"Koulouri","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"181\u20136","key":"10.1016\/j.ejim.2019.08.008_bb0300","article-title":"Differentiation of pituitary adenomas from other sellar and parasellar tumors by 99mTc(V)-DMSA scintigraphy","volume":"43","author":"Yamamura","year":"2003","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.ejim.2019.08.008_bb0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1530\/eje.0.1330038","article-title":"Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas","volume":"133","author":"Lastoria","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"755\u2013767","key":"10.1016\/j.ejim.2019.08.008_bb0310","article-title":"In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand","volume":"45","author":"de Herder","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jcem.83.1.4493","article-title":"Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas","volume":"83","author":"Ferone","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"437\u2013445","key":"10.1016\/j.ejim.2019.08.008_bb0320","article-title":"Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide","volume":"52","author":"Colao","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2967\/jnmt.113.136291","article-title":"Pituitary incidentaloma found on O-(2-18F-fluoroethyl)-l-tyrosine PET","volume":"42","author":"Currie","year":"2014","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.ejim.2019.08.008_bb0330","first-page":"44","article-title":"Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism","volume":"46","author":"Xiangsong","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejim.2019.08.008_bb0335","article-title":"Utility of (13)N-ammonia PET\/CT to detect pituitary tissue in patients with pituitary adenomas","author":"Wang","year":"2018","journal-title":"Acad Radiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519302936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620519302936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:29:19Z","timestamp":1760606959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620519302936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":67,"alternative-id":["S0953620519302936"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2019.08.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pituitary in nuclear medicine imaging","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}